Approved Symbol
|
Approved Name |
Location
|
No. of Studies (significant/non-significant/trend)
|
SLC6A3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
5p15.3 |
68(42/25/1)
|
DRD4 |
dopamine receptor D4 |
11p15.5 |
67(49/18/0)
|
COMT |
catechol-O-methyltransferase |
22q11.21 |
25(5/20/0)
|
SLC6A4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
17q11.2 |
25(13/12/0)
|
DRD5 |
dopamine receptor D5 |
4p16.1 |
22(14/6/2)
|
DBH |
dopamine beta-hydroxylase (dopamine beta-monooxygenase) |
9q34 |
20(11/9/0)
|
MAOA |
monoamine oxidase A |
Xp11.4-p11.3 |
20(13/7/0)
|
SNAP25 |
synaptosomal-associated protein, 25kDa |
20p12-p11.2 |
18(13/5/0)
|
SLC6A2 |
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
16q12.2 |
16(10/5/1)
|
BDNF |
brain-derived neurotrophic factor |
11p14.1 |
14(8/6/0)
|
HTR1B |
5-hydroxytryptamine (serotonin) receptor 1B |
6q13 |
13(5/8/0)
|
ADRA2A |
adrenergic, alpha-2A-, receptor |
10q24-q26 |
12(4/8/0)
|
HTR2A |
5-hydroxytryptamine (serotonin) receptor 2A |
13q14-q21 |
12(6/6/0)
|
DRD2 |
dopamine receptor D2 |
11q22-q23 |
10(3/7/0)
|
TPH2 |
tryptophan hydroxylase 2 |
12q15 |
10(7/3/0)
|
DRD1 |
dopamine receptor D1 |
5q34-q35 |
8(5/3/0)
|
DRD3 |
dopamine receptor D3 |
3q13.3 |
8(1/7/0)
|
ADRA2C |
adrenergic, alpha-2C-, receptor |
4p16.3 |
7(2/4/1)
|
CHRNA4 |
cholinergic receptor, nicotinic, alpha 4 |
20 |
7(4/3/0)
|
TH |
tyrosine hydroxylase |
11p15.5 |
7(2/5/0)
|
DDC |
dopa decarboxylase (aromatic L-amino acid decarboxylase) |
7p11 |
6(5/1/0)
|
MAOB |
monoamine oxidase B |
Xp11.4-p11.3 |
6(2/4/0)
|
TPH1 |
tryptophan hydroxylase 1 |
11p15.3-p14 |
6(2/4/0)
|
HTR2C |
5-hydroxytryptamine (serotonin) receptor 2C |
Xq24 |
5(2/3/0)
|